• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖化血红蛋白与成人心脏手术后胸骨伤口感染的风险:系统评价和荟萃分析。

Glycated Hemoglobin and the Risk of Sternal Wound Infection After Adult Cardiac Surgery: A Systematic Review and Meta-Analysis.

机构信息

Heart Center, Turku University Hospital and Department of Surgery, University of Turku, Turku, Finland; Department of Surgery, University of Oulu, Oulu, Finland.

Department of Surgery, Satakunta Central Hospital, Pori, Finland; Department of Plastic and General Surgery, Turku University Hospital and University of Turku, Turku, Finland.

出版信息

Semin Thorac Cardiovasc Surg. 2019 Autumn;31(3):465-467. doi: 10.1053/j.semtcvs.2019.02.029. Epub 2019 Mar 6.

DOI:10.1053/j.semtcvs.2019.02.029
PMID:30851374
Abstract

Increased glycated hemoglobin (HbA1c) has been shown to increase the risk of mortality, myocardial infarction, and stroke after cardiac surgery, whereas its impact on the development of sternal wound infection (SWI) is less clear. A systematic review and meta-analysis were performed to evaluate the impact of preoperative HbA1c levels on the occurrence of SWI after adult cardiac surgery. Fourteen studies including 17,609 patients fulfilled the inclusion criteria and were included in this analysis. Diagnostic test meta-analysis of studies evaluating baseline HbA1c cut-off values ranging from 6% to 7% DCCT units (42-53 mmol/mol IFCC units) showed that the diagnostic odds ratio for deep SWI was 3.02 (95% confidence interval [CI] 2.10-4.35), while the diagnostic odds ratio for any SWI was 2.81 (95% CI 2.02-3.93). Binary meta-analysis confirmed that baseline HbA1c cut-off values ranging from 6% to 7% increased the risk for deep SWI (pooled incidence 2.7% vs 0.8%, risk ratio [RR] 3.01, 95% CI 2.32-3.90, I 0%). Six studies included only diabetics and their pooled RR for deep SWI was 2.94 (1.59-5.45, I 0%). Nine studies evaluated an HbA1c cut-off value of 7% and their RR for deep SWI was 3.22 (95% CI 2.38-4.37, I 0%). The RR for any SWI was 2.92 (95% CI 2.42-3.53, I 0%). This pooled analysis showed that the risk of SWI is substantially increased when preoperative HbA1c levels are over 6-7%. Future studies should evaluate whether postponing surgery for optimization of the glycemic control can reduce the risk of SWI in patients with increased levels of HbA1c.

摘要

糖化血红蛋白(HbA1c)升高已被证明会增加心脏手术后的死亡率、心肌梗死和中风风险,但其对胸骨伤口感染(SWI)发展的影响尚不清楚。进行了系统评价和荟萃分析,以评估术前 HbA1c 水平对成人心脏手术后 SWI 发生的影响。符合纳入标准的 14 项研究共纳入 17609 例患者,纳入本分析。评估基线 HbA1c 截断值范围为 6%至 7%DCCT 单位(42-53mmol/mol IFCC 单位)的研究的诊断测试荟萃分析显示,深部 SWI 的诊断优势比为 3.02(95%置信区间[CI]2.10-4.35),而任何 SWI 的诊断优势比为 2.81(95%CI2.02-3.93)。二项式荟萃分析证实,基线 HbA1c 截断值范围为 6%至 7%增加了深部 SWI 的风险(汇总发生率 2.7%与 0.8%,风险比[RR]3.01,95%CI2.32-3.90,I 0%)。6 项研究仅纳入糖尿病患者,其深部 SWI 的汇总 RR 为 2.94(1.59-5.45,I 0%)。9 项研究评估了 HbA1c 截断值为 7%,其深部 SWI 的 RR 为 3.22(95%CI2.38-4.37,I 0%)。任何 SWI 的 RR 为 2.92(95%CI2.42-3.53,I 0%)。该汇总分析表明,当术前 HbA1c 水平超过 6-7%时,SWI 的风险显著增加。未来的研究应评估是否推迟手术以优化血糖控制是否可以降低 HbA1c 水平升高患者的 SWI 风险。

相似文献

1
Glycated Hemoglobin and the Risk of Sternal Wound Infection After Adult Cardiac Surgery: A Systematic Review and Meta-Analysis.糖化血红蛋白与成人心脏手术后胸骨伤口感染的风险:系统评价和荟萃分析。
Semin Thorac Cardiovasc Surg. 2019 Autumn;31(3):465-467. doi: 10.1053/j.semtcvs.2019.02.029. Epub 2019 Mar 6.
2
Glycated Hemoglobin and Risk of Sternal Wound Infection After Isolated Coronary Surgery.糖化血红蛋白与单纯冠状动脉手术后胸骨伤口感染风险
Circ J. 2016 Dec 22;81(1):36-43. doi: 10.1253/circj.CJ-16-0778. Epub 2016 Dec 8.
3
Utility of glycated hemoglobin screening in patients undergoing elective coronary artery surgery: Prospective, cohort study from the E-CABG registry.糖化血红蛋白筛查在择期冠状动脉旁路移植术患者中的应用:来自 E-CABG 登记处的前瞻性队列研究。
Int J Surg. 2018 May;53:354-359. doi: 10.1016/j.ijsu.2018.04.021. Epub 2018 Apr 14.
4
The Association Between Preoperative Hemoglobin A1C and Postoperative Glycemic Variability on 30-Day Major Adverse Outcomes Following Isolated Cardiac Valvular Surgery.单纯心脏瓣膜置换术后30天主要不良结局中术前糖化血红蛋白与术后血糖变异性之间的关联。
Anesth Analg. 2017 Jan;124(1):16-22. doi: 10.1213/ANE.0000000000001715.
5
Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery?糖化血红蛋白(HbA1c)在预测冠状动脉搭桥手术后的死亡率和发病率结果方面是否有作用?
Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):1000-8. doi: 10.1093/icvts/ivt351. Epub 2013 Sep 10.
6
Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative.血管质量倡议研究中,术前糖化血红蛋白水平与糖尿病患者行下肢动脉旁路术时不良肢体事件风险增加的关系。
J Vasc Surg. 2019 Oct;70(4):1225-1234.e1. doi: 10.1016/j.jvs.2018.12.041. Epub 2019 Mar 7.
7
Preoperative Glycosylated Hemoglobin: A Risk Factor for Patients Undergoing Coronary Artery Bypass.术前糖化血红蛋白:冠状动脉搭桥手术患者的一个危险因素。
Ann Thorac Surg. 2017 Aug;104(2):606-612. doi: 10.1016/j.athoracsur.2016.12.020. Epub 2017 Mar 6.
8
Association between HbA1c and deep sternal wound infection after coronary artery bypass: a systematic review and meta-analysis.糖化血红蛋白与冠状动脉搭桥术后深部胸骨伤口感染之间的关联:一项系统评价和荟萃分析。
J Cardiothorac Surg. 2024 Feb 4;19(1):51. doi: 10.1186/s13019-024-02549-6.
9
The impact of hemoglobin A on outcomes after lower extremity bypass.血红蛋白 A 对下肢旁路手术后结局的影响。
J Vasc Surg. 2021 Apr;73(4):1332-1339.e5. doi: 10.1016/j.jvs.2020.05.036. Epub 2020 Jul 28.
10
Hemoglobin A1c and preoperative glycemia as a decision tool to help minimise sternal wound complications: a retrospective study in OPCAB patients.糖化血红蛋白和术前血糖作为一种决策工具,有助于减少 OPCAB 患者胸骨伤口并发症:回顾性研究。
J Cardiothorac Surg. 2021 Jul 20;16(1):198. doi: 10.1186/s13019-021-01580-1.

引用本文的文献

1
Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility study.优化糖尿病患者心脏手术的预后:OCTOPuS试点可行性研究
Health Technol Assess. 2025 Aug;29(39):1-31. doi: 10.3310/POYW3311.
2
Effect of glycaemic control on coronary artery bypass grafting outcomes - a United Kingdom centre experience.血糖控制对冠状动脉旁路移植术结局的影响——英国一家中心的经验
JRSM Cardiovasc Dis. 2025 Mar 18;14:20480040251325918. doi: 10.1177/20480040251325918. eCollection 2025 Jan-Dec.
3
Rationale and strategies for improving glycaemic control in diabetic patients undergoing cardiac surgery: a narrative review.
改善接受心脏手术的糖尿病患者血糖控制的基本原理和策略:一项叙述性综述
J Thorac Dis. 2024 Nov 30;16(11):8088-8102. doi: 10.21037/jtd-24-1112. Epub 2024 Nov 6.
4
Complications and revision rates after total shoulder arthroplasty are similar between patients with and without diabetes mellitus.全肩关节置换术后,糖尿病患者与非糖尿病患者的并发症及翻修率相似。
Shoulder Elbow. 2024 Sep 25:17585732241278207. doi: 10.1177/17585732241278207.
5
Impact of systematic diabetes screening on peri-operative infections in patients undergoing cardiac surgery.心脏手术患者接受系统性糖尿病筛查对围手术期感染的影响。
Sci Rep. 2024 Jun 20;14(1):14182. doi: 10.1038/s41598-024-65064-7.
6
Concomitant Panniculectomy in Abdominal Wall Reconstruction: A Narrative Review Focusing on Obese Patients.腹壁重建术中同期行腹壁脂肪切除术:以肥胖患者为重点的叙述性综述
Clin Pract. 2024 Apr 22;14(2):653-660. doi: 10.3390/clinpract14020052.
7
Association between HbA1c and deep sternal wound infection after coronary artery bypass: a systematic review and meta-analysis.糖化血红蛋白与冠状动脉搭桥术后深部胸骨伤口感染之间的关联:一项系统评价和荟萃分析。
J Cardiothorac Surg. 2024 Feb 4;19(1):51. doi: 10.1186/s13019-024-02549-6.
8
Impact of Perioperative Prophylaxis With Activity on Risk of Surgical-Site Infection After Pancreas Transplantation.围手术期预防性使用活性药物对胰腺移植术后手术部位感染风险的影响。
Transplant Direct. 2023 Jun 8;9(7):e1496. doi: 10.1097/TXD.0000000000001496. eCollection 2023 Jul.
9
Correlation between the Control of Blood Glucose Level and HbA1C and the Incidence of Surgical Site Infection after Emergent Surgery for the Lower Limb Fracture among Type II DM Patients Aged More Than 50 Years Old.50岁以上II型糖尿病患者下肢骨折急诊手术后血糖水平及糖化血红蛋白控制与手术部位感染发生率的相关性
J Clin Med. 2022 Sep 22;11(19):5552. doi: 10.3390/jcm11195552.
10
The Problem of Wound Healing in Diabetes-From Molecular Pathways to the Design of an Animal Model.糖尿病创面愈合问题——从分子途径到动物模型设计。
Int J Mol Sci. 2022 Jul 19;23(14):7930. doi: 10.3390/ijms23147930.